BridgeBio Pharma, Inc. (BBIO) Gross profit 2021–2025
BridgeBio Pharma, Inc. (BBIO) annual gross profit history from SEC filings — each fiscal year as reported.
$481.1MFY2025 · since FY2021: $66.6M → $481.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $481.1M | +120.7% |
| FY2024 | $218.0M | +3079.6% |
| FY2023 | $6.9M | -90.8% |
| FY2022 | $74.2M | +11.4% |
| FY2021 | $66.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice